Announce Date | 07/30/2025 |
EPS Normalized Actual | $3.58 (Beat by $0.36) |
EPS GAAP Actual | $3.58 (Beat by $0.36) |
Revenue Actual | $13.47B |
Revenue Surprise | Beat by $13470M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 17.098 | 5.89 | 15.06809 | 20.06512 | 1 |
Dec 2027 | 16.7005 | 6.03 | 15.39109 | 19.7528 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.01 | 2.01 | 13.47B | -61.28% | 13470M |
FQ4 2024 (Dec 2024) | -7.71 | -7.71 | 12.523B | -24.2% | 12523M |
FQ3 2024 (Sep 2024) | 1.15 | 1.15 | 19.49B | 57.15% | 19490M |
FQ2 2024 (Jun 2024) | 0 | 0 | 14.883B | 20.08% | 14883M |
FQ1 2024 (Mar 2024) | 3.17 | 3.17 | 21.725B | 28.43% | 21725M |
FQ4 2023 (Dec 2023) | 3.66 | 3.66 | 15.553B | 14.27% | 15553M |
FQ3 2023 (Sep 2023) | 0 | 0 | 8.352B | -145.21% | 8352M |
FQ4 2001 (Dec 2001) | 0 | 0 | 0B | NAN% | 0M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2028 (Dec 2028) | 4.26072 | -- | 3.96307 | 4.808 | 6 |
FQ3 2028 (Sep 2028) | 4.50757 | -- | 4.26004 | 4.88072 | 6 |
FQ2 2028 (Jun 2028) | 4.27413 | -- | 4.03941 | 4.62795 | 6 |
FQ1 2028 (Mar 2028) | 3.95462 | -- | 3.67836 | 4.46258 | 6 |
FQ4 2027 (Oct 2027) | 4.3962 | -- | 4.3962 | 4.3962 | 4 |
FQ3 2027 (Jul 2027) | 4.1856 | -- | 4.1856 | 4.1856 | 3 |
FQ2 2027 (Jun 2027) | 4.2273 | -- | 3.87542 | 4.85715 | 8 |
FQ1 2027 (Mar 2027) | 4.0811 | -- | 3.74139 | 4.68916 | 8 |
FQ4 2026 (Oct 2026) | 4.0436 | -- | 3.69132 | 4.61484 | 3 |
FQ3 2026 (Jul 2026) | 3.8691 | -- | 3.53202 | 4.41569 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2028 (Dec 2028) | 19.91B | -- | 18.84B | 21.88B | 1 |
FQ3 2028 (Sep 2028) | 17.15B | -- | 16.43B | 18.25B | 1 |
FQ2 2028 (Jun 2028) | 16.54B | -- | 15.84B | 17.59B | 1 |
FQ1 2028 (Mar 2028) | 15.2B | -- | 14.38B | 16.7B | 1 |
FQ4 2027 (Oct 2027) | 16.9B | -- | 16.9B | 16.9B | 2 |
FQ3 2027 (Jul 2027) | 16.01B | -- | 16.01B | 16.01B | 2 |
FQ2 2027 (Jun 2027) | 16.04B | -- | 15.01B | 17.87B | 4 |
FQ1 2027 (Mar 2027) | 15.87B | -- | 14.86B | 17.69B | 4 |
FQ4 2026 (Oct 2026) | 13.44B | -- | 12.54B | 14.9B | 2 |
FQ3 2026 (Jul 2026) | 13.23B | -- | 12.34B | 14.66B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
1
EPS # of in-lines
3
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.01 | 2.01 | 100% | |
FQ4 2024 (Dec 2024) | -7.71 | -7.71 | 100% | |
FQ3 2024 (Sep 2024) | 1.15 | 1.15 | 100% | |
FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
FQ1 2024 (Mar 2024) | 3.17 | 3.17 | 100% | |
FQ4 2023 (Dec 2023) | 3.66 | 3.66 | 100% | |
FQ3 2023 (Sep 2023) | 0 | 0 | NAN% | |
FQ4 2001 (Dec 2001) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $13.47B | $13470M | 100% |
FQ4 2024 (Dec 2024) | $0B | $12.52B | $12523M | 100% |
FQ3 2024 (Sep 2024) | $0B | $19.49B | $19490M | 100% |
FQ2 2024 (Jun 2024) | $0B | $14.88B | $14883M | 100% |
FQ1 2024 (Mar 2024) | $0B | $21.73B | $21725M | 100% |
FQ4 2023 (Dec 2023) | $0B | $15.55B | $15553M | 100% |
FQ3 2023 (Sep 2023) | $0B | $8.35B | $8352M | 100% |
FQ4 2001 (Dec 2001) | $0B | $0B | $0M | NAN% |